US Stock MarketDetailed Quotes
CYCN Cyclerion Therapeutics
- 1.8700
- -0.2200-10.53%
Trading Nov 21 13:19 ET
5.07MMarket Cap-877P/E (TTM)
1.9920High1.5500Low438.24KVolume1.9800Open2.0900Pre Close700.72KTurnover30.77%Turnover RatioLossP/E (Static)2.71MShares5.250052wk High0.62P/B2.66MFloat Cap1.550052wk Low--Dividend TTM1.42MShs Float420.0000Historical High--Div YieldTTM21.15%Amplitude1.5500Historical Low1.5980Avg Price1Lot Size
Cyclerion Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 75.26%-1.72M | 83.13%-1.11M | 69.89%-1.87M | 86.47%-5.49M | 301.77%14.21M | 30.06%-6.94M | 39.41%-6.56M | 51.59%-6.21M | -11.21%-40.61M | 18.39%-7.04M |
| Net income from continuing operations | -109.56%-723K | 68.38%-1.32M | 77.83%-1.54M | 88.06%-5.26M | 76.52%-1.69M | 172.08%7.57M | 68.77%-4.18M | 46.42%-6.95M | 14.66%-44.08M | 33.03%-7.22M |
| Depreciation and amortization | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -86.23%65K | --0 |
| Change In working capital | 65.28%-768K | 101.16%32K | -262.42%-510K | -61.44%-4.6M | 105.26%50K | -104.63%-2.21M | -422.37%-2.75M | 118.78%314K | -302.41%-2.85M | -130.54%-951K |
| -Change in receivables | ---44K | ---- | ---- | 2,300.00%96K | --0 | --0 | ---- | ---- | -85.19%4K | 125.86%131K |
| -Change in prepaid assets | -258.81%-505K | 140.25%192K | -43.70%134K | 195.12%363K | 205.58%284K | 186.49%318K | -232.50%-477K | 401.27%238K | 209.82%123K | 26.50%-269K |
| -Change in payables and accrued expense | 91.60%-219K | 93.81%-160K | -570.83%-644K | -60.24%-5.54M | 71.73%-255K | -96.98%-2.61M | -815.79%-2.58M | 93.98%-96K | -449.29%-3.46M | -127.38%-902K |
| -Change in other current assets | --0 | --0 | --0 | 0.00%481K | -76.40%21K | -41.98%76K | 59.40%212K | 34.38%172K | -68.99%481K | -30.47%89K |
| Cash from discontinued investing activities | -15.75M | 0 | ||||||||
| Operating cash flow | 75.26%-1.72M | 83.13%-1.11M | 69.89%-1.87M | 47.69%-21.25M | 78.12%-1.54M | 30.06%-6.94M | 39.41%-6.56M | 51.59%-6.21M | -11.21%-40.61M | 18.39%-7.04M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---- | ---- | --10.4M | --0 | --10.4M | ---- | ---- | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 17,224.14%5.02M | 0 | 0 | -99.91%29K | -85.88%12K | ||||
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | 17,224.14%5.02M | 41,566.67%5M | --0 | ---- | ---- | -89.72%29K | -85.88%12K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | ---- | ---- | 17,224.14%5.02M | --0 | --0 | ---- | ---- | -99.91%29K | -85.88%12K |
| Net cash flow | ||||||||||
| Beginning cash position | -18.67%4.59M | -20.55%5.7M | -43.42%7.57M | -75.20%13.38M | -55.36%9.11M | -81.40%5.64M | -82.57%7.17M | -75.20%13.38M | -7.33%53.96M | -67.35%20.41M |
| Current changes in cash | -149.50%-1.72M | 27.76%-1.11M | 69.89%-1.87M | 85.66%-5.82M | 78.08%-1.54M | 134.97%3.47M | 85.83%-1.53M | 51.59%-6.21M | -849.29%-40.58M | 17.72%-7.03M |
| Effect of exchange rate changes | --0 | -166.67%-2K | -500.00%-4K | 166.67%8K | -50.00%4K | --0 | 400.00%3K | 200.00%1K | -25.00%3K | 166.67%8K |
| End cash Position | -68.47%2.87M | -18.67%4.59M | -20.55%5.7M | -43.42%7.57M | -43.42%7.57M | -55.36%9.11M | -81.40%5.64M | -82.57%7.17M | -75.20%13.38M | -75.20%13.38M |
| Free cash flow | 75.26%-1.72M | 83.13%-1.11M | 69.89%-1.87M | 47.69%-21.25M | 78.12%-1.54M | 30.06%-6.94M | 39.41%-6.56M | 51.59%-6.21M | -11.19%-40.61M | 18.39%-7.04M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
